BioArctic AB Statistics
Total Valuation
BioArctic AB has a market cap or net worth of 3.17 billion. The enterprise value is 2.96 billion.
| Market Cap | 3.17B |
| Enterprise Value | 2.96B |
Important Dates
The next estimated earnings date is Wednesday, February 18, 2026.
| Earnings Date | Feb 18, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 74.24M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +0.60% |
| Shares Change (QoQ) | +0.06% |
| Owned by Insiders (%) | 30.63% |
| Owned by Institutions (%) | 46.56% |
| Float | 55.73M |
Valuation Ratios
The trailing PE ratio is 29.89 and the forward PE ratio is 87.05.
| PE Ratio | 29.89 |
| Forward PE | 87.05 |
| PS Ratio | 15.59 |
| PB Ratio | 15.17 |
| P/TBV Ratio | 15.17 |
| P/FCF Ratio | 28.09 |
| P/OCF Ratio | 27.40 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 20.32, with an EV/FCF ratio of 26.26.
| EV / Earnings | 27.94 |
| EV / Sales | 13.76 |
| EV / EBITDA | 20.32 |
| EV / EBIT | 20.53 |
| EV / FCF | 26.26 |
Financial Position
The company has a current ratio of 4.18, with a Debt / Equity ratio of 0.02.
| Current Ratio | 4.18 |
| Quick Ratio | 3.14 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.04 |
| Interest Coverage | 40.41 |
Financial Efficiency
Return on equity (ROE) is 69.23% and return on invested capital (ROIC) is 723.18%.
| Return on Equity (ROE) | 69.23% |
| Return on Assets (ROA) | 43.46% |
| Return on Invested Capital (ROIC) | 723.18% |
| Return on Capital Employed (ROCE) | 64.18% |
| Weighted Average Cost of Capital (WACC) | -0.59% |
| Revenue Per Employee | 1.67M |
| Profits Per Employee | 869,612 |
| Employee Count | 122 |
| Asset Turnover | 1.04 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, BioArctic AB has paid 18.35 million in taxes.
| Income Tax | 18.35M |
| Effective Tax Rate | 14.75% |
Stock Price Statistics
The stock price has increased by +72.56% in the last 52 weeks. The beta is -0.90, so BioArctic AB's price volatility has been lower than the market average.
| Beta (5Y) | -0.90 |
| 52-Week Price Change | +72.56% |
| 50-Day Moving Average | 25.51 |
| 200-Day Moving Average | 21.00 |
| Relative Strength Index (RSI) | 56.43 |
| Average Volume (20 Days) | 452 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioArctic AB had revenue of 203.37 million and earned 106.09 million in profits. Earnings per share was 1.19.
| Revenue | 203.37M |
| Gross Profit | 197.43M |
| Operating Income | 136.30M |
| Pretax Income | 124.44M |
| Net Income | 106.09M |
| EBITDA | n/a |
| EBIT | 136.30M |
| Earnings Per Share (EPS) | 1.19 |
Balance Sheet
The company has 199.72 million in cash and 4.94 million in debt, with a net cash position of 194.78 million.
| Cash & Cash Equivalents | 199.72M |
| Total Debt | 4.94M |
| Net Cash | 194.78M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 208.99M |
| Book Value Per Share | 2.36 |
| Working Capital | 202.50M |
Cash Flow
In the last 12 months, operating cash flow was 115.72 million and capital expenditures -2.83 million, giving a free cash flow of 112.89 million.
| Operating Cash Flow | 115.72M |
| Capital Expenditures | -2.83M |
| Free Cash Flow | 112.89M |
| FCF Per Share | n/a |
Margins
Gross margin is 97.08%, with operating and profit margins of 67.02% and 52.17%.
| Gross Margin | 97.08% |
| Operating Margin | 67.02% |
| Pretax Margin | 61.19% |
| Profit Margin | 52.17% |
| EBITDA Margin | n/a |
| EBIT Margin | 67.02% |
| FCF Margin | 55.51% |
Dividends & Yields
BioArctic AB does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.60% |
| Shareholder Yield | -0.60% |
| Earnings Yield | 3.35% |
| FCF Yield | 3.56% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |